A Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of ENC1018 Capsules in Patients With Moderate-to-severe Active Ulcerative Colitis (UC)
NANot yet recruitingINTERVENTIONAL
Enrollment
10
Participants
Timeline
Start Date
July 1, 2025
Primary Completion Date
August 1, 2025
Study Completion Date
April 1, 2026
Conditions
Ulcerative Colitis (UC)
Interventions
DRUG
ENC1018 capsule administration group
ENC1018 capsules were taken orally once a day for 14 days.
All Listed Sponsors
lead
Tang-Du Hospital
OTHER
NCT07062185 - A Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of ENC1018 Capsules in Patients With Moderate-to-severe Active Ulcerative Colitis (UC) | Biotech Hunter | Biotech Hunter